CClinicalTrials.gg
CompletedNCT03853941Updated May 23, 2022

Adherence to Activity Limitations in Diabetes

An interventional study of Intervention in Diabetes and Foot Ulcer, sponsored by University of Nottingham. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-23.

Sponsored by University of Nottingham · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
49
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to develop and test a theory-based motivation communication training programme for healthcare professionals working with diabetic foot ulcer patients. The investigators will explore the acceptability of the training programme and examine whether the training leads to changes in healthcare professionals' communication style, and results in greater adherence to treatment recommendations (i.e., reduced weight-bearing) in patients.

Read the detailed description

This is a proof of concept, two-arm non-randomised, controlled before-and-after study. Patient outcomes (perceptions of healthcare professional communication style, treatment self-regulation and adherence to activity reduction) will be collected first during a control/usual care period. Healthcare professionals will then receive the theory-based motivation communication training programme. Subsequently a new group of patients will be recruited as the intervention group and the same outcome measures collected. Control group outcomes will be compared to intervention group outcomes. Interviews will be conducted with healthcare professionals and patients to assess acceptability of the intervention.

02

Conditions studied

  • Diabetes
  • Foot Ulcer

Browse trials for

Keywords

  • Motivation
  • Communication
  • Healthcare Professional
  • Training
  • Adherence
  • Diabetes
  • Foot Ulcer
03

In context

Foot Ulcer

691 studies on the registry are indexed under Foot Ulcer; 96 are open to participants now.

This study's enrollment of 49 is below the median of 60 across 562 interventional studies indexed under Foot Ulcer.

Browse Foot Ulcer studies →

Lead sponsor

University of Nottingham is the lead sponsor of 455 studies on the registry; 77 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Be aged 18 years and over
  • Have diabetes according to WHO criteria
  • Have a diabetic foot ulcer being treated at the foot clinic at Royal Derby Hospital
  • Be able to communicate and complete questionnaire measures in English
  • Have capacity to consent and agree to participate.

Exclusion criteria

Exclusion Criteria:

  • Patients who are not currently engaging in walking behaviour (e.g., wheelchair-bound patients) or have other physical limitations that restrict ability to use an accelerometer will be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
Double (Participant, Investigator)
Enrollment
49 participants (actual)

Study arms

  • No intervention
    Control

    Patients in the control group will receive treatment as usual.

  • Experimental
    Experimental

    The experimental group will receive clinical treatment as usual, however, the healthcare professionals treating them will have received training on how to enhance patient adherence via the use of a motivationally supportive communication style. Thus, the style/language healthcare professionals use to convey usual treatment recommendations may differ.

    Behavioral: Intervention

Interventions

  • BehavioralIntervention

    Theory-based communication training programme delivered to healthcare professionals

06

What researchers measure

Primary outcomes

  1. Change in healthcare professionals' communication style

    Measured using the 6-item Health Care Climate Questionnaire, and indicated by patients' perceptions of healthcare professional autonomy support being higher in the intervention group compared to the control group.

    Time frame: Baseline

Secondary outcomes

  1. Change in patients' adherence to activity reduction recommendations

    Measured using an accelerometer. Patients will be asked to wear the accelerometer daily for 1 month.

    Time frame: 1 month

  2. Change in patient treatment self-regulation

    Treatment self-regulation is the reasons why patients may adhere or not and is a potential mechanism explaining the relationship between healthcare professional autonomy support and patient adherence to treatment recommendations.

    Time frame: Baseline

  3. Acceptability of the intervention

    Assessed via interviews with healthcare professionals who have taken part in the training programme and patients.

    Time frame: Healthcare professional interviews 4-6 weeks following training; Patient interviews 4-6 weeks following baseline

  4. Fidelity of delivery

    A researcher will sit in on up to 20 patient/healthcare professional consultation sessions (10 prior to training and 10 post training). The researcher will record observations of the communication style used by the healthcare professionals within the sessions. Observations will be assessed for fidelity of delivery using a checklist developed specifically for this study. Data from pre and post-training observations will be compared for differences in communication style.

    Time frame: Baseline

07

Study locations

1 site
  • Royal Derby Hospital
    Derby, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03853941
Lead sponsor
University of Nottingham
Responsible party
Sponsor
First posted
Feb 26, 2019
Start date
Mar 21, 2019
Primary completion
Feb 14, 2020
Completion
Sep 10, 2020
Last update
May 23, 2022

Study contacts

Jennie Hancox, PhD
principal investigator · University of Nottingham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion